Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Asthma Devices Companies

At the intersection of technology and respiratory health, Asthma Devices companies specialize in developing innovative devices for managing and treating asthma. These organizations contribute to improved quality of life for individuals with asthma through effective and user-friendly solutions.

Asthma Devices Market

 


Latest Asthma Devices Companies Updates:


Flovent Discontinuation: GSK's discontinuation of Flovent HFA, a popular corticosteroid inhaler, at the start of 2024, has caused concerns for patients facing insurance hurdles and potential cost issues with the authorized generic version.


Symbicort Transition: AstraZeneca announced the planned discontinuation of Symbicort in certain markets by 2025, focusing on newer inhaled corticosteroid/long-acting beta-agonist (ICS/LABA) combinations like Breztri Aerosphere.


Teva's ProAir Respiclar 160HFA Approval: The FDA approved Teva's generic version of ProAir Respiclar 160 HFA, an albuterol rescue inhaler, offering a potential cost-effective option for patients.


Trudell Medical's Trudell Medical Microhaler Launch: Trudell Medical launched its Microhaler, a new dry powder inhaler designed for easier portability and use, particularly for children and elderly patients.


List of Asthma Devices Key companies in the market:



  • GlaxoSmithKline plc. (Europe)

  • Merck & Co., Inc. (U.S.)

  • 3M (U.S.)

  • Aristopharma Ltd. (Asia Pacific)

  • SRS PHARMACEUTICALS PVT. LTD. (Asia Pacific)

  • AstraZeneca (Europe), Baxter. (U.S.)

  • Boehringer Ingelheim GmbH (Europe)

  • Koninklijke Philips N.V. (Europe)


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.